Intravenous treprostinil as add-on therapy in patients with pulmonary arterial hypertension

In patients with pulmonary arterial hypertension (PAH) who have an insufficient response to oral or inhaled therapies, current guidelines recommend the use of parenteral prostacyclin analogues, although the efficacy of this approach is unknown.

Source: The Journal of Heart and Lung Transplantation - May 5, 2019 Category: Transplant Surgery Authors: Karen M Olsson, Manuel J Richter, Jan C Kamp, Henning Gall, Alexander Heine, Hossein-Ardeshir Ghofrani, Jan Fuge, Ralf Ewert, Marius M Hoeper Tags: Original Clinical Science Source Type: research